The Motley Fool

Key Data Points

Primary metrics and data points about Keryx Biopharmaceuticals.
Current Price: $4.25
Prev Close: $4.02
Open: $4.10
Bid: $4.17
Ask: $4.25
Day's Range: $3.96 - $4.34
52wk Range: $3.04 - $17.97
Volume: 3,545,424
Avg Vol 2,761,209
Market Cap: $447M
P/E (ttm): -2.96
EPS (ttm): ($1.36)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Keryx Biopharmaceuticals.

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

KERX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Keryx Biopharmaceuticals.
CAPS Rating 2 out of 5
396 Outperform
69 Underperform
CAPS All Stars
49 Outperform
22 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Bentsur, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Keryx Biopharmaceuticals

Primary metrics and data points about Keryx Biopharmaceuticals.